Accessibility navigation

Gene-editing technology in lung cancer: models and therapies

Zhu, L. (2023) Gene-editing technology in lung cancer: models and therapies. Theoretical and Natural Science, 4. pp. 344-350. ISSN 2753-8826

Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.


It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.54254/2753-8818/4/20220586


Cancer is a disease that develops when the body's cells expand unchecked. Lung cancer is a general term for cancer that first appears in the lungs. The most common cancer that is lethal is lung cancer. Lung cancer is the commonly diagnosed cancer diagnosed between both female and male in the US, only behind certain forms of skin cancer. Lung cancer is most often caused by smoking. Additionally, smoking other tobacco products (including pipes or cigars), breathing secondhand smoke, being linked to radon or radon at work or home, and lung cancer risk may be increased by having a history of the disease in your family. Furthermore, new developments in genome editing technology have dramatically increased the possibility of curing cancer at its origin. This article discusses potential gene editing methods for treating lung cancer and systematically identifies the locations of common gene changes in the condition.

Item Type:Article
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > Department of Food and Nutritional Sciences > Human Nutrition Research Group
ID Code:112231
Publisher:EWA Publishing


Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation